{"id":251194,"date":"2022-01-14T00:00:00","date_gmt":"2022-01-14T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidop0024-biopharma-diabetic-macular-edema-epidemiology-asia\/"},"modified":"2026-03-31T10:41:09","modified_gmt":"2026-03-31T10:41:09","slug":"epidop0024-biopharma-diabetic-macular-edema-epidemiology-asia-pacific","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidop0024-biopharma-diabetic-macular-edema-epidemiology-asia-pacific\/","title":{"rendered":"Diabetic Macular Edema &#8211; Epidemiology &#8211; Asia-Pacific"},"content":{"rendered":"<p>Clarivate Epidemiology\u2019s coverage of diabetic macular edema (<abbr title=\"diabetic macular edema\">DME<\/abbr>) comprises epidemiological estimates of key patient populations in 45 countries. We report the prevalence of <abbr title=\"diabetic macular edema\">DME<\/abbr> for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>In addition to forecasting prevalent patient populations, we estimate the number of drug-treatment opportunities in specific lines of therapy in the major mature pharmaceutical markets.<\/p>\n<p>Clarivate Epidemiology\u2019s <abbr title=\"diabetic macular edema\">DME<\/abbr><abbr title=\"diabetic macular edema\"> <\/abbr> forecast will answer the following questions:<\/p>\n<ul class=\"round-bullets\">\n<li>Of all people with <abbr title=\"diabetic macular edema\">DME<\/abbr>, how many in each country have been formally diagnosed?<\/li>\n<li>Of all people diagnosed with <abbr title=\"diabetic macular edema\">DME<\/abbr>, how many in each of the major mature pharmaceutical markets are drug-treated?<\/li>\n<li>How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of <abbr title=\"diabetic macular edema\">DME<\/abbr> over the forecast period?<\/li>\n<\/ul>\n<p>All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to <span class=\"abbreviation-guard\">MS <\/span>Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>In total, Clarivate Epidemiology forecasts the following nine <abbr title=\"diabetic macular edema\">DME<\/abbr> patient populations:<\/p>\n<ul class=\"round-bullets\">\n<li>Total prevalent cases.<\/li>\n<li><abbr title=\"diabetic macular edema\">DME<\/abbr> with mild nonproliferative diabetic retinopathy.<\/li>\n<li><abbr title=\"diabetic macular edema\">DME<\/abbr> with moderate nonproliferative diabetic retinopathy.<\/li>\n<li><abbr title=\"diabetic macular edema\">DME<\/abbr> with severe nonproliferative diabetic retinopathy.<\/li>\n<li><abbr title=\"diabetic macular edema\">DME<\/abbr> with proliferative diabetic retinopathy.<\/li>\n<li>Diagnosed prevalent cases.<\/li>\n<li>Undiagnosed prevalent cases.<\/li>\n<li>Diagnosed drug-treated cases.<\/li>\n<li>Diagnosed non-drug-treated cases.<\/li>\n<\/ul>\n<p>Note: Coverage may vary by country.<\/p>\n","protected":false},"template":"","class_list":["post-251194","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-diabetic-macular-edema","biopharma-therapy-areas-ophthalmology","biopharma-product-epidemiology","biopharma-date-960"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251194\/revisions"}],"predecessor-version":[{"id":283634,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251194\/revisions\/283634"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=251194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}